DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock
$7,18
Cena · Sie 19, 2026
Dane fundamentalne na dzień Sie 6, 2026
Zakres 52 tyg.
$5–$18
15% of range
Ocena Analityków
SELL
10 analysts
Cena Docelowa
$7
P/E (TTM)
-1.3
ROE
-55.8%
Marża Zysku Netto
-183.8%
O Ginkgo Bioworks Holdings, Inc. Class A Common Stock Przegląd firmy z Wikipedii
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.
Czytaj więcej
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.
History
In 2014, Ginkgo was the first biotechnology company to join the Y Combinator start-up accelerator program.
On 16 December 2020, it was reported that Ginkgo Bioworks would acquire the primary assets of Novogy's Microbial Engineering Platform. 2020 also saw the company acquire property worth $25 million from Marcus Partners for the construction of a new 219,000 square foot laboratory building, after razing existing structures, located in the Raymond L Flynn Marine Park. As of 2021, the company also occupied 200,000 square feet of the Innovation and Design Building (aka IDB) in the Park. Ginkgo also occupied facilities in Cambridge, where most MIT-spin outs resided at the time.
Growth of Ginkgo up to 2021 had been driven by "robust venture capital funding" and entry into the COVID-19 testing market. This included $45 million from Viking Global in 2015.
On 11 May 2021, Ginkgo Bioworks announced plans of going public through a merger with SPAC Soaring Eagle at a $17.5 billion valuation.
On 14 May 2021, Ginkgo announced its new ticker for the NYSE will be "DNA". The ticker was previously used by Genentech, who stopped using the ticker after they were acquired by Roche. Trading began on September 17, 2021. The investment management firm Baillie Gifford became the largest shareholder (15%) with the purchase of 167.75 million shares on 31 March 2022.
On 14 March 2022, it was reported that Ginkgo Bioworks signed a Definitive Agreement to Acquire FGen AG, a leading bioengineering company and its proprietary ultra-high-throughput screening platform.
On 6 June 2022, it was reported that Ginkgo Bioworks has acquired assets from real-time metabolite monitoring company, Bitome.
On 25 July 2022, Ginkgo Bioworks agreed to acquire Zymergen for $300 million in an all-stock deal.
On 27 July 2022, it was reported that Ginkgo Bioworks would acquire Bayer's Biologics Research & Development site, located in West Sacramento. Ginkgo will enter into a new multi-year platform collaboration with Bayer. The deal includes the integration of the R&D platform assets from Joyn Bio, a joint-venture between Leaps by Bayer investments and Ginkgo Bioworks.
On 4 October 2022, it was reported that Ginkgo Bioworks would acquire France-based adaptive laboratory evolution instruments developer Altar and California-based Circularis to strengthen capabilities in cell and gene therapy.
In October 2022, Bloomberg News reported that Ginkgo Bioworks partnered with Intelligence Advanced Research Projects Activity to create a software tool to help detect when biological organisms have been genetically engineered. The tool known as ENDAR (short for Engineered Nucleotide Detection and Ranking) could be used to provide an early warning of bioweapons and other man-made biological threats.
Fraud allegations
On 6 October 2021, a market research firm published a report accusing Ginkgo of embellishing its revenue in a complex scheme highly dependent on related-party transactions. The report prompted an inquiry into Ginkgo by the United States Department of Justice. In November 2021, Ginkgo was sued in a shareholder lawsuit alleging it misrepresented its revenue sources in statements regarding its merger with a special-purpose acquisition company. As of 2021, the company could not name a single significant product that is manufactured and sold using its organisms.
In March 2023, the former Attorney General of Louisiana launched an investigation into the officers and directors of Ginkgo.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
DNA Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$7.18
Kapitalizacja Rynkowa
$443M
P/E (TTM)
-1.3
EPS (TTM)
$-5.64
Przychody (TTM)
$170M
Stopa dywidendy
—
ROE
-55.8%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$5 – $18
DNA Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$170M
2019-12-31
→
2025-12-31
EPS
$-5.64
2019-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-179M
2022-12-31
→
2025-12-31
Marże
-183.8%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
DNA
Mediana porównawcza
P/E (TTM)
-1.3
17.5
P/S (TTM)
2.6
3.3
P/B
0.9
2.1
Price / FCF (Cena / FCF)
-2.5
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
DNA
Mediana porównawcza
Operating Margin (Marża Operacyjna)
-185.3%
—
Net Profit Margin (Marża Zysku Netto)
-183.8%
-56.5%
ROA
-25.1%
-17.2%
ROE
-55.8%
-41.3%
ROIC
-61.8%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
DNA
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
4.9
4.9
Quick Ratio (Wskaźnik Szybkości)
4.7
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
DNA
Mediana porównawcza
Revenue YoY (Przychody R/R)
-25.1%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
-29.1%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
17.3%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
DNA
Mediana porównawcza
DNA Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
SPRZEDAJ
10 analityków
- Mocne kupno 0 0,0%
- Kup 1 10,0%
- Trzymaj 2 20,0%
- Sprzedaj 5 50,0%
- Mocna sprzedaż 2 20,0%
12-miesięczny cel cenowy
2 analityków · 2026-08-15
Mediana
$7.00
Teraz
$7.18
Niski
$5.00
Wysoki
$9.00
Średni cel
$7.00
-2,5%
Średnia cel
$7.00
-2,5%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.05%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.75 | $-0.92 | 0.17% |
| 31 marca 2026 | $-1.39 | $-1.09 | -0.30% |
| 31 grudnia 2025 | $-1.41 | $-1.47 | 0.06% |
| 30 września 2025 | $-1.45 | $-1.25 | -0.20% |
| 30 czerwca 2025 | $-1.10 | $-1.58 | 0.48% |
| 31 marca 2025 | $-1.68 | $-1.79 | 0.11% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| DNA | $484M | -1.5 | -25.1% | -183.8% | -55.8% | — |
| AZTA | $1.32B | -23.5 | 3.5% | -9.4% | -3.3% | 45.5% |
| CYRX | $479M | 6.9 | 12.4% | 44.4% | 15.3% | 47.1% |
| CTKB | $649M | 505.0 | 0.52% | -33.0% | -18.5% | 51.8% |
| MLAB | $489M | 73.1 | 3.4% | 2.7% | 3.7% | 63.5% |
| OABI | — | — | — | — | — | — |
| TKNO | $204M | -11.9 | 7.3% | -42.6% | -23.8% | 33.2% |
| PACB | $565M | -1.0 | 3.9% | -341.5% | -1634.9% | 28.6% |
| LAB | $495M | -6.4 | -6.2% | -87.8% | -17.6% | 49.9% |
| LFCR | $249M | -5.3 | 0.47% | -30.0% | -461.3% | 31.3% |
| CDXS | $147M | -3.3 | 18.6% | -62.5% | -82.8% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 15
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $170M | $227M | $251M | $478M | $314M | $77M | $54M | |
| R&D Expense | $244M | $424M | $581M | $1.05B | $1.15B | $160M | $96M | |
| SG&A Expense | $183M | $246M | $385M | $1.43B | $863M | $38M | $29M | |
| Operating Expenses | $485M | $787M | $1.12B | $2.69B | $2.14B | $214M | $126M | |
| Operating Income | $-315M | $-560M | $-864M | $-2.21B | $-1.83B | $-137M | $-72M | |
| Interest Expense | · | · | $93.0K | $106.0K | $2M | $2M | $2M | |
| Other Non-op | $2M | $12M | $-29M | $88M | $-10M | $12M | · | |
| Pretax Income | $-314M | $-548M | $-893M | $-2.12B | $-1.84B | $-125M | $-120M | |
| Income Tax | $-837.0K | $-479.0K | $-71.0K | $-15M | $-1M | $2M | $22.0K | |
| Net Income | $-313M | $-547M | $-893M | $-2.10B | $-1.83B | $-127M | $-119M | |
| EPS (Basic) | $-5.64 | $-10.54 | $-18.37 | $-50.15 | $-1.35 | $-0.10 | $-0.10 | |
| EPS (Diluted) | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 | $-0.10 | $-0.10 | |
| Shares (Basic) | 55,457,676 | 51,894,639 | 48,610,507 | 41,976,537 | 1,359,849,000 | 1,274,766,915 | 1,149,000,417 | |
| Shares (Diluted) | 55,457,676 | 51,894,639 | 48,610,507 | 41,995,972 | 1,360,373,000 | 1,274,766,915 | 1,149,000,417 | |
| EBITDA | $-315M | $-560M | $-864M | $-2.21B | · | · | · |
Bilans 28
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $167M | $562M | $944M | $1.32B | $1.55B | $381M | $495M | |
| Short-term Investments | $255M | $0 | · | · | · | · | · | |
| Receivables | $24M | $22M | $17M | $81M | $132M | $17M | · | |
| Inventory | · | · | $46.0K | $4M | $3M | $3M | · | |
| Prepaid Expense | $25M | $19M | $40M | $52M | $34M | $21M | · | |
| Other Current Assets | · | · | $362.0K | $487.0K | $698.0K | $680.0K | · | |
| Current Assets | $472M | $603M | $1.00B | $1.45B | $1.72B | $427M | · | |
| PP&E (Net) | $167M | $204M | $188M | $315M | $146M | $121M | · | |
| PP&E (Gross) | $355M | $365M | $309M | $408M | $207M | $155M | · | |
| Accum. Depreciation | $188M | $161M | $121M | $93M | $61M | $34M | · | |
| Goodwill | · | $0 | $49M | $60M | $21M | $2M | $2M | |
| Intangibles | $53M | $73M | $83M | $111M | $22M | $3M | · | |
| Other Non-current Assets | $9M | $55M | $58M | $89M | $44M | $6M | · | |
| Total Assets | $1.12B | $1.38B | $1.67B | $2.54B | $2.07B | $675M | · | |
| Accounts Payable | $11M | $14M | $9M | $10M | $8M | $14M | · | |
| Accrued Liabilities | · | · | · | $115M | $93M | $31M | · | |
| Short-term Debt | · | · | · | · | · | $300.0K | · | |
| Current Liabilities | $96M | $107M | $164M | $173M | $135M | $73M | · | |
| Capital Leases | $417M | $439M | $222M | $413M | $0 | · | · | |
| Other Non-current Liabilities | $23M | $17M | $24M | $31M | $36M | $3M | · | |
| Total Liabilities | $611M | $661M | $568M | $803M | $504M | $205M | · | |
| Common Stock | $6.0K | $5.0K | $5.0K | $190.0K | $161.0K | $129.0K | · | |
| Paid-in Capital | $6.66B | $6.56B | $6.39B | $6.14B | $3.80B | $929M | · | |
| Retained Earnings | $-6.15B | $-5.84B | $-5.29B | $-4.40B | $-2.30B | $-468M | · | |
| AOCI | $2M | $-2M | $1M | $-3M | $-2M | $0 | · | |
| Stockholders' Equity | $509M | $716M | $1.10B | $1.74B | $1.57B | $470M | · | |
| Liabilities + Equity | $1.12B | $1.38B | $1.67B | $2.54B | $2.07B | $675M | · | |
| Shares Outstanding | 58,207,298 | 54,365,785,000 | 50,032,873 | 47,299,399 | 40,284,804 | 1,288,596,000 | · |
Przepływy pieniężne 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $59M | $63M | $71M | $43M | $29M | $14M | $11M | |
| Stock-based Comp | $82M | $112M | $230M | $1.93B | $1.61B | $476.0K | $771.0K | |
| Deferred Tax | $-1M | $-936.0K | $-801.0K | $-15M | $0 | $0 | · | |
| Amort. of Intangibles | $19M | $18M | $16M | $6M | $1M | $500.0K | $500.0K | |
| Restructuring | $11M | $19M | · | · | · | · | · | |
| Operating Cash Flow | $-171M | $-320M | $-296M | $-252M | $-254M | $-136M | $-45M | |
| CapEx | $8M | $63M | $41M | $52M | $57M | $58M | $22M | |
| Investing Cash Flow | $-240M | $-62M | $-81M | $-67M | $-73M | $-67M | $-75M | |
| Stock Issued | $19M | $0 | $0 | · | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | $408.0K | |
| Net Stock Activity | $19M | · | · | · | · | · | · | |
| Financing Cash Flow | $18M | $-2M | $-3M | $95M | $1.53B | $90M | $410M | |
| Net Change in Cash | $-393M | $-384M | $-380M | $-223M | $1.21B | $-113M | $291M | |
| Taxes Paid | $192.0K | $0 | $23.0K | $981.0K | $9M | $0 | · | |
| Free Cash Flow | $-179M | $-382M | $-336M | $-304M | · | · | · | |
| Levered FCF | · | · | $-336M | $-305M | · | · | · |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -185.3% | -246.5% | -343.8% | -462.4% | · | · | · | |
| Net Margin | -183.8% | -240.9% | -355.1% | -440.6% | · | · | · | |
| Pretax Margin | -184.3% | -241.2% | -355.1% | -444.1% | · | · | · | |
| EBITDA Margin | -185.3% | -246.5% | -343.8% | -462.4% | · | · | · | |
| ROA | -25.1% | -36.0% | -42.5% | -91.3% | · | · | · | |
| ROE | -55.8% | -72.3% | -76.0% | -132.4% | · | · | · | |
| ROIC | -61.8% | -78.1% | -78.8% | -126.3% | · | · | · |
Płynność i wypłacalność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | 5.6 | 6.1 | 8.4 | · | · | · | |
| Quick Ratio | 4.7 | 5.4 | 5.9 | 8.1 | · | · | · | |
| Interest Coverage | · | · | -9294.7 | -20839.2 | · | · | · |
Efektywność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | 0.1 | 0.2 | · | · | · | |
| Receivables Turnover | 7.4 | 11.6 | 5.1 | 4.5 | · | · | · |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -25.1% | -9.7% | -47.4% | 52.2% | 309.4% | · | · | |
| Revenue CAGR 3Y | -29.1% | -10.2% | 48.6% | · | · | · | · | |
| Revenue CAGR 5Y | 17.3% | · | · | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $170M | $227M | $251M | $478M | $314M | · | · | |
| Net Income TTM | $-313M | $-547M | $-893M | $-2.10B | $-1.83B | · | · | |
| Market Cap | $484M | $534M | $135.29B | $127.90B | · | · | · | |
| P/E | -1.5 | -0.9 | -3.7 | -1.3 | -239.1 | · | · | |
| P/S | 2.8 | 2.4 | 538.0 | 267.7 | · | · | · | |
| P/B | 1.0 | 0.7 | 123.3 | 73.7 | · | · | · | |
| P / Tangible Book | 1.1 | 0.8 | 140.2 | 81.7 | 351.4 | · | · | |
| P / Cash Flow | -2.8 | -1.7 | -457.8 | -507.1 | · | · | · | |
| P / FCF | -2.7 | -1.4 | -402.3 | -420.1 | · | · | · | |
| Earnings Yield | -67.9% | -107.3% | -27.2% | -74.3% | -0.42% | · | · |
Rachunek zysków i strat 15
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20M | $19M | $33M | $39M | $39M | $38M | $44M | $89M | $56M | $38M | $35M | $55M | $81M | $81M | $98M | $66M | |
| Cost of Revenue | $2M | $3M | · | · | $5M | $4M | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $46M | $50M | $50M | $69M | $53M | $71M | $76M | $77M | $134M | $136M | $117M | $157M | $144M | $163M | $178M | $261M | |
| SG&A Expense | $31M | $38M | $46M | $45M | $35M | $40M | $57M | $52M | $66M | $70M | $89M | $82M | $102M | $111M | $121M | $435M | |
| Operating Expenses | $79M | $91M | $104M | $129M | $97M | $119M | $147M | $144M | $279M | $216M | $213M | $342M | $265M | $296M | $329M | $721M | |
| Operating Income | $-59M | $-71M | $-71M | $-90M | $-58M | $-81M | $-104M | $-55M | $-223M | $-178M | $-178M | $-286M | $-184M | $-216M | $-231M | $-655M | |
| Other Non-op | $1M | $-5M | $-11M | $9M | $5M | $-2M | $-4M | $-2M | $6M | $12M | $-34M | $-17M | $11M | $11M | $43M | $-15M | |
| Pretax Income | $-57M | $-76M | $-81M | $-81M | $-53M | $-83M | $-108M | $-57M | $-217M | $-166M | $-212M | $-303M | $-173M | $-205M | $-188M | $-670M | |
| Income Tax | $128.0K | $-80.0K | $-643.0K | $1.0K | $-283.0K | $88.0K | $-325.0K | $-375.0K | $190.0K | $31.0K | $-198.0K | $-22.0K | $67.0K | $82.0K | $-15M | $-28.0K | |
| Net Income | $-47M | $-83M | $-81M | $-81M | $-60M | $-91M | $-108M | $-56M | $-217M | $-166M | $-212M | $-303M | $-173M | $-205M | $-175M | $-670M | |
| EPS (Basic) | $-0.75 | $-1.39 | $-1.41 | $-1.45 | $-1.10 | $-1.68 | $-1.92 | $-1.08 | $-4.23 | $-3.31 | $-11.96 | $-6.21 | $-0.09 | $-0.11 | $-48.96 | $-0.41 | |
| EPS (Diluted) | · | · | $-1.41 | $-1.45 | $-1.10 | $-1.68 | $-1.91 | $-1.08 | $-4.23 | $-3.32 | $-11.96 | $-6.21 | $-0.09 | $-0.11 | $-49.01 | $-0.41 | |
| Shares (Basic) | 62,094,356 | 59,563,454 | -109,276,643 | 55,633,718 | 54,858,982 | 54,241,619 | -101,827,409 | 52,240,559 | 51,370,029 | 50,111,460 | -3,848,559,493 | 48,770,000 | 1,933,437,000 | 1,914,963,000 | -3,211,245,963 | 1,630,911,000 | |
| Shares (Diluted) | · | · | -109,276,643 | 55,633,718 | 54,858,982 | 54,241,619 | -101,860,455 | 52,246,129 | 51,375,599 | 50,133,366 | -3,850,233,493 | 48,770,000 | 1,933,437,000 | 1,916,637,000 | -3,211,226,528 | 1,630,911,000 | |
| EBITDA | $-59M | $-71M | · | $-90M | $-66M | $-89M | · | $-55M | $-223M | $-178M | · | $-286M | $-184M | $-216M | · | $-653M |
Bilans 25
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $144M | $167M | $111M | $204M | $312M | $562M | $616M | $730M | $840M | $944M | $1.05B | $1.11B | $1.21B | $1.32B | $1.30B | |
| Short-term Investments | · | · | $255M | $384M | $356M | $13M | $0 | · | · | · | · | · | · | · | · | · | |
| Receivables | $13M | $20M | $24M | $21M | $22M | $26M | $22M | $23M | $19M | $24M | · | $62M | $68M | $83M | · | $114M | |
| Inventory | · | · | · | · | · | · | · | · | · | · | · | $70.0K | $391.0K | $3M | · | $6M | |
| Prepaid Expense | $17M | $16M | $25M | $22M | $26M | $20M | $19M | $22M | $34M | $38M | · | $29M | $48M | $34M | · | $38M | |
| Current Assets | $333M | $410M | $472M | $506M | $523M | $565M | $603M | $662M | $783M | $903M | · | $1.14B | $1.22B | $1.33B | · | $1.46B | |
| PP&E (Net) | $157M | $163M | $168M | $177M | $186M | $198M | $204M | $211M | $211M | $196M | · | $202M | $294M | $314M | · | $188M | |
| PP&E (Gross) | $355M | $352M | $358M | $359M | $360M | $361M | $365M | $362M | $347M | $326M | · | $322M | $413M | $421M | · | $271M | |
| Accum. Depreciation | $198M | $189M | $191M | $182M | $173M | $163M | $161M | $151M | $136M | $130M | · | $121M | $118M | $107M | · | $83M | |
| Goodwill | · | · | · | · | · | · | $0 | $0 | $0 | $48M | $49M | $58M | $59M | $59M | $60M | $29M | |
| Intangibles | $44M | $49M | $57M | $62M | $66M | $69M | $73M | $80M | $91M | $77M | · | $100M | $105M | $109M | · | $48M | |
| Other Non-current Assets | $1M | $40M | $47M | $47M | $47M | $47M | $55M | $60M | $60M | $61M | · | $97M | $98M | $97M | · | $44M | |
| Total Assets | $990M | $1.03B | $1.12B | $1.19B | $1.23B | $1.29B | $1.38B | $1.48B | $1.63B | $1.58B | · | $2.03B | $2.29B | $2.42B | · | $1.87B | |
| Accounts Payable | $10M | $16M | $11M | $11M | $11M | $11M | $14M | $16M | $23M | $27M | · | $11M | $14M | $22M | · | $11M | |
| Current Liabilities | $73M | $80M | $96M | $115M | $97M | $116M | $107M | $114M | $166M | $169M | · | $168M | $163M | $192M | · | $125M | |
| Capital Leases | $404M | $411M | $417M | $423M | $429M | $435M | $439M | $446M | $452M | $234M | · | $404M | $411M | $404M | · | · | |
| Other Non-current Liabilities | $16M | $22M | $23M | $17M | $18M | $15M | $17M | $18M | $21M | $25M | · | $19M | $20M | $29M | · | $35M | |
| Total Liabilities | $570M | $590M | $611M | $629M | $618M | $646M | $661M | $683M | $792M | $594M | · | $774M | $788M | $810M | · | $431M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $206.0K | $202.0K | · | $198.0K | $196.0K | $194.0K | · | $165.0K | |
| Paid-in Capital | $6.70B | $6.67B | $6.66B | $6.63B | $6.60B | $6.58B | $6.56B | $6.53B | $6.51B | $6.45B | · | $6.33B | $6.28B | $6.21B | · | $5.67B | |
| Retained Earnings | $-6.28B | $-6.23B | $-6.15B | $-6.07B | $-5.99B | $-5.93B | $-5.84B | $-5.73B | $-5.67B | $-5.46B | · | $-5.08B | $-4.78B | $-4.60B | · | $-4.23B | |
| AOCI | $950.0K | $1M | $2M | $2M | $2M | $-850.0K | $-2M | $263.0K | $-2M | $-2M | · | $-3M | $-1M | $-2M | · | $-8M | |
| Stockholders' Equity | $420M | $443M | $509M | $560M | $613M | $647M | $716M | $798M | $833M | $987M | $1.10B | $1.25B | $1.50B | $1.61B | $1.74B | $1.43B | |
| Liabilities + Equity | $990M | $1.03B | $1.12B | $1.19B | $1.23B | $1.29B | $1.38B | $1.48B | $1.63B | $1.58B | · | $2.03B | $2.29B | $2.42B | · | $1.87B | |
| Shares Outstanding | 63,711,102 | 61,660,788 | 58,207,298 | 56,836,246 | 55,425,334 | 54,698,246 | 54,365,785 | 53,082,000 | 2,078,737,000 | 2,033,624,000 | 50,032,873 | 1,972,725,000 | 1,954,704,000 | 1,933,880,000 | 47,299,399 | 1,648,263,224 |
Przepływy pieniężne 12
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $13M | $14M | $14M | $16M | $15M | $16M | $17M | $17M | $13M | $13M | $21M | $18M | $19M | $16M | $8M | |
| Stock-based Comp | $8M | $16M | $21M | $18M | $22M | $17M | $21M | $14M | $37M | $41M | $43M | $53M | $61M | $73M | $108M | $563M | |
| Amort. of Intangibles | $4M | $4M | $5M | $5M | $4M | $4M | $5M | $5M | $5M | $3M | $3M | $4M | $4M | $4M | $3M | $1M | |
| Restructuring | · | · | $706.0K | $2M | $4M | · | $-666.0K | $3M | $12M | · | · | $0 | $0 | · | · | · | |
| Operating Cash Flow | $-44M | $-47M | $-48M | $-32M | $-40M | $-52M | $-42M | $-104M | $-84M | $-89M | $-58M | $-74M | $-74M | $-91M | $-105M | $-28M | |
| CapEx | $3M | $2M | $5.0K | $0 | $38.0K | $8M | $14M | $15M | $27M | $7M | $3M | $4M | $14M | $19M | $26M | $13M | |
| Investing Cash Flow | $11M | $23M | $95M | $-73M | $-64M | $-199M | $-13M | $-10M | $-27M | $-12M | $-47M | $-3M | $-11M | $-19M | $30M | $-46M | |
| Stock Issued | · | · | $9M | $10M | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $16M | $-19.0K | $8M | $10M | $-98.0K | $-207.0K | $-203.0K | $-465.0K | $-226.0K | $-845.0K | $-632.0K | $-315.0K | $-1M | $-888.0K | $98M | $-280.0K | |
| Net Change in Cash | $-17M | $-24M | $55M | $-94M | $-104M | $-250M | $-56M | $-114M | $-111M | $-102M | $-105M | $-77M | $-87M | $-111M | $24M | $-75M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Free Cash Flow | · | $-49M | · | · | · | $-59M | · | · | · | $-96M | · | · | · | $-110M | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -290.5% | -366.5% | · | -231.8% | -132.1% | -184.1% | · | -62.0% | -396.7% | -469.1% | · | -516.7% | -228.6% | -267.3% | · | -983.5% | |
| Net Margin | -231.7% | -424.1% | · | -207.9% | -121.6% | -188.2% | · | -63.3% | -386.4% | -437.2% | · | -546.4% | -215.1% | -254.0% | · | -1007.6% | |
| Pretax Margin | -283.8% | -391.0% | · | -207.9% | -122.1% | -188.1% | · | -63.8% | -386.1% | -437.2% | · | -546.5% | -215.0% | -253.9% | · | -1007.7% | |
| EBITDA Margin | -290.5% | -366.5% | · | -231.8% | -132.1% | -184.1% | · | -62.0% | -396.7% | -469.1% | · | -516.7% | -228.6% | -267.3% | · | -983.5% | |
| ROA | -4.2% | -7.1% | · | -6.0% | -4.2% | -6.3% | · | -3.2% | -11.1% | -8.3% | · | -15.5% | -8.1% | -9.2% | · | -33.3% | |
| ROE | -9.0% | -15.2% | · | -11.9% | -8.3% | -11.1% | · | -5.5% | -18.6% | -12.8% | · | -22.5% | -11.4% | -12.9% | · | -44.8% | |
| ROIC | -14.0% | -16.1% | · | -16.1% | -10.6% | -13.8% | · | -6.9% | -26.8% | -18.0% | · | -22.9% | -12.2% | -13.4% | · | -45.5% |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 5.2 | · | 4.4 | 5.4 | 4.9 | · | 5.8 | 4.7 | 5.3 | · | 6.8 | 7.5 | 6.9 | · | 11.7 | |
| Quick Ratio | 1.3 | 2.1 | · | 4.5 | 6.0 | 3.0 | · | 5.6 | 4.5 | 5.1 | · | 6.6 | 7.2 | 6.7 | · | 11.3 |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 1.1 | 0.8 | · | 1.7 | 2.4 | 1.9 | · | 2.1 | 1.3 | 0.7 | · | 0.6 | 0.7 | 0.6 | · | 0.8 |
Wycena (TTM) 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $118M | $146M | · | $226M | $243M | $232M | · | $239M | $230M | $255M | · | $283M | $372M | $460M | · | $457M | |
| Net Income TTM | $-270M | $-315M | · | $-288M | $-425M | $-530M | · | $-742M | $-859M | $-847M | · | $-1.35B | $-1.72B | $-2.13B | · | $-2.03B | |
| Market Cap | $631M | $378M | · | $829M | $624M | $312M | · | $433M | $27.77B | $94.36B | · | $142.83B | $145.43B | $102.88B | · | $205.70B | |
| P/E | -1.9 | -1.2 | · | -2.7 | -1.4 | -0.6 | · | -0.5 | -1.0 | -4.8 | · | -10.6 | -72.9 | -40.9 | · | -98.3 | |
| P/S | 5.4 | 2.6 | · | 3.7 | 2.6 | 1.3 | · | 1.8 | 120.7 | 370.6 | · | 504.5 | 390.6 | 223.6 | · | 450.1 | |
| P/B | 1.5 | 0.9 | · | 1.5 | 1.0 | 0.5 | · | 0.5 | 33.3 | 95.6 | · | 114.0 | 96.7 | 64.0 | · | 143.4 | |
| P / Tangible Book | 1.7 | 1.0 | · | 1.7 | 1.1 | 0.5 | · | 0.6 | 37.4 | 109.5 | · | 130.5 | 108.6 | 71.4 | · | 151.5 | |
| P / Cash Flow | · | -8.1 | · | · | · | -6.1 | · | · | · | -1057.2 | · | · | · | -1135.8 | · | · | |
| P / FCF | · | -7.8 | · | · | · | -5.3 | · | · | · | -983.2 | · | · | · | -935.1 | · | · | |
| Earnings Yield | -53.6% | -86.6% | · | -36.4% | -71.9% | -180.9% | · | -182.1% | -103.7% | -21.0% | · | -9.4% | -1.4% | -2.4% | · | -1.0% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $170M | $227M | $251M | $478M | $314M |
| Marża Operacyjna % | -185.3% | -246.5% | -343.8% | -462.4% | — |
| Zysk netto | $-313M | $-547M | $-893M | $-2.10B | $-1.83B |
| Rozwodniony EPS | $-5.64 | $-10.54 | $-18.37 | $-50.20 | $-1.39 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 4.9 | 5.6 | 6.1 | 8.4 | — |
| Wskaźnik Szybkości | 4.7 | 5.4 | 5.9 | 8.1 | — |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-179M | $-382M | $-336M | $-304M | — |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
- W którą akcję "Wspaniałej Siódemki" teraz inwestuje Cathie Wood
- Yahoo announces AI-powered experiences for Yahoo Finance and Yahoo Sports
- This Warren Buffett Stock Is Beating the S&P 500 in 2026
- Prokurator General Kalifornii pozwa następcę 23andMe w związku z naruszeniem danych w 2023 roku
- Zakazy reklam dotyczących zestawów do samodzielnego pobierania wymazów DNA jako wprowadzające w błąd
- Jim Cramer o BillionToOne: „Mówię kupuj”
- Jak oparzenie słoneczne zainspirowało nowy sposób magazynowania energii
- Sprzedawcy marihuany pozwani za rzekome nieostrzeganie konsumentów o ryzyku
- Wzrost o 30% w 1 miesiąc, czy Zcash jest lepszym zakupem niż Bitcoin?
- SCHQ vs. TLT: Podobny DNA obligacji skarbowych, bardzo różne koszty i okres.
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 204 emitenci · $269.0M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 39 (+13 vs poprzedni kw.) | 17 (-11 vs poprzedni kw.) | 65 (+23 vs poprzedni kw.) | 35 (-12 vs poprzedni kw.) | +6.2M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | $35 449 338 | 3 577 128 | 13,18% | Akcje |
| Erste Asset Management GmbH | $25 902 147 | 2 536 939 | 9,63% | Akcje |
| BAILLIE GIFFORD & CO | $23 701 242 | 2 391 649 | 8,81% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $20 685 074 | 2 087 293 | 7,69% | Akcje |
| Anchorage Capital Group, L.L.C. | $17 306 457 | 1 746 363 | 6,43% | Akcje |
| STATE STREET CORP | $14 591 187 | 1 472 370 | 5,43% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $10 292 812 | 1 038 369 | 3,83% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9 293 628 | 937 803 | 3,46% | Akcje |
| Allianz Asset Management GmbH | $7 787 258 | 785 798 | 2,90% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $6 329 279 | 638 676 | 2,35% | Akcje |
| SB INVESTMENT ADVISERS (UK) LTD | $6 052 324 | 610 729 | 2,25% | Akcje |
| Prescott Group Capital Management, L.L.C. | $5 369 684 | 541 845 | 2,00% | Akcje |
| GOLDMAN SACHS GROUP INC | $5 364 154 | 541 287 | 1,99% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $5 349 973 | 539 856 | 1,99% | Akcje |
| BANK OF AMERICA CORP /DE/ | $4 760 754 | 480 399 | 1,77% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4 109 677 | 414 700 | 1,53% | Opcja kupna |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3 910 555 | 394 607 | 1,45% | Akcje |
| EXCHANGE TRADED CONCEPTS, LLC | $3 555 540 | 358 783 | 1,32% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $3 480 392 | 351 200 | 1,29% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $3 326 886 | 335 710 | 1,24% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $3 097 598 | 312 573 | 1,15% | Akcje |
| Coastal Bridge Advisors, LLC | $2 743 256 | 276 817 | 1,02% | Akcje |
| BALANCE CAPITAL PARTNERS L.P. | $1 972 179 | 199 009 | 0,73% | Akcje |
| ALGERT GLOBAL LLC | $1 784 395 | 180 060 | 0,66% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $1 746 449 | 176 231 | 0,65% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $1 637 935 | 165 281 | 0,61% | Akcje |
| PEAK6 LLC | $1 619 294 | 163 400 | 0,60% | Opcja kupna |
| CAXTON ASSOCIATES LLP | $1 532 552 | 154 647 | 0,57% | Akcje |
| D. E. Shaw & Co., Inc. | $1 499 938 | 151 356 | 0,56% | Akcje |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $1 387 400 | 140 000 | 0,52% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 297 219 | 130 900 | 0,48% | Opcja sprzedaży |
| CITADEL ADVISORS LLC | $1 233 973 | 124 518 | 0,46% | Akcje |
| JPMORGAN CHASE & CO | $1 154 383 | 113 064 | 0,43% | Akcje |
| a16z Capital Management, L.L.C. | $1 075 909 | 108 568 | 0,40% | Akcje |
| CITADEL ADVISORS LLC | $1 073 253 | 108 300 | 0,40% | Opcja kupna |
| Numerai GP LLC | $1 036 606 | 104 602 | 0,39% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $974 718 | 98 357 | 0,36% | Akcje |
| WOLVERINE TRADING, LLC | $964 467 | 72 900 | 0,36% | Opcja kupna |
| Ensign Peak Advisors, Inc | $931 332 | 93 979 | 0,35% | Akcje |
| Bank of New York Mellon Corp | $818 843 | 82 628 | 0,30% | Akcje |
| PANAGORA ASSET MANAGEMENT INC | $803 592 | 81 089 | 0,30% | Akcje |
| MARSHALL WACE, LLP | $772 356 | 77 937 | 0,29% | Akcje |
| Swiss National Bank | $744 865 | 75 163 | 0,28% | Akcje |
| ALLSTATE CORP | $698 209 | 70 455 | 0,26% | Akcje |
| Mariner, LLC | $667 488 | 67 359 | 0,25% | Akcje |
| IEQ CAPITAL, LLC | $624 766 | 63 044 | 0,23% | Akcje |
| ALLEN OPERATIONS LLC | $613 935 | 61 951 | 0,23% | Akcje |
| RHUMBLINE ADVISERS | $610 615 | 61 617 | 0,23% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $609 079 | 61 461 | 0,23% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $599 099 | 60 454 | 0,22% | Akcje |
| BROWN ADVISORY INC | $586 731 | 59 206 | 0,22% | Akcje |
| BlackRock, Inc. | $526 895 | 53 168 | 0,20% | Akcje |
| EDGEWOOD MANAGEMENT LLC | $495 500 | 50 000 | 0,18% | Akcje |
| WOLVERINE TRADING, LLC | $492 156 | 37 200 | 0,18% | Opcja sprzedaży |
| Quadrature Capital Ltd | $456 732 | 46 088 | 0,17% | Akcje |
| MORGAN STANLEY | $447 427 | 45 149 | 0,17% | Akcje |
| Shay Capital LLC | $444 384 | 44 842 | 0,17% | Akcje |
| LPL Financial LLC | $427 257 | 43 114 | 0,16% | Akcje |
| CITIGROUP INC | $426 893 | 43 077 | 0,16% | Akcje |
| JANE STREET GROUP, LLC | $414 238 | 41 800 | 0,15% | Opcja kupna |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $387 709 | 39 123 | 0,14% | Akcje |
| Casdin Capital, LLC | $361 646 | 36 493 | 0,13% | Akcje |
| CITADEL ADVISORS LLC | $347 841 | 35 100 | 0,13% | Opcja sprzedaży |
| Dynamic Technology Lab Private Ltd | $347 000 | 34 996 | 0,13% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $342 005 | 55 792 | 0,13% | Akcje |
| GROUP ONE TRADING LLC | $326 138 | 32 910 | 0,12% | Akcje |
| AlphaQuest LLC | $309 788 | 37 279 | 0,12% | Akcje |
| Mitsubishi UFJ Asset Management Co., Ltd. | $301 532 | 30 427 | 0,11% | Akcje |
| Welch & Forbes LLC | $297 300 | 30 000 | 0,11% | Akcje |
| MetLife Investment Management, LLC | $285 111 | 28 770 | 0,11% | Akcje |
| AXQ CAPITAL, LP | $262 387 | 26 477 | 0,10% | Akcje |
| BARCLAYS PLC | $258 919 | 26 127 | 0,10% | Akcje |
| IMC-Chicago, LLC | $240 922 | 24 311 | 0,09% | Akcje |
| Man Group plc | $239 901 | 24 208 | 0,09% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $238 425 | 24 059 | 0,09% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $222 975 | 22 500 | 0,08% | Akcje |
| Russell Investments Group, Ltd. | $222 885 | 22 491 | 0,08% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $217 356 | 21 933 | 0,08% | Akcje |
| Modera Wealth Management, LLC | $216 316 | 21 828 | 0,08% | Akcje |
| MARTINGALE ASSET MANAGEMENT L P | $209 062 | 21 096 | 0,08% | Akcje |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $203 116 | 22 345 | 0,08% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $189 123 | 30 852 | 0,07% | Akcje |
| Walleye Capital LLC | $188 944 | 19 066 | 0,07% | Akcje |
| Invesco Ltd. | $186 209 | 18 790 | 0,07% | Akcje |
| Trexquant Investment LP | $178 420 | 18 004 | 0,07% | Akcje |
| SIMPLEX TRADING, LLC | $178 330 | 17 995 | 0,07% | Akcje |
| Comprehensive Financial Management LLC | $174 971 | 17 656 | 0,07% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $172 474 | 17 404 | 0,06% | Akcje |
| Boston Standard Wealth Management, LLC | $164 995 | 15 165 | 0,06% | Akcje |
| DEUTSCHE BANK AG\ | $163 763 | 16 525 | 0,06% | Akcje |
| Creative Planning | $156 974 | 15 840 | 0,06% | Akcje |
| Vanguard Global Advisers, LLC | $155 904 | 15 732 | 0,06% | Akcje |
| Squarepoint Ops LLC | $155 478 | 15 689 | 0,06% | Akcje |
| MERCER GLOBAL ADVISORS INC /ADV | $153 664 | 15 506 | 0,06% | Akcje |
| ExodusPoint Capital Management, LP | $148 343 | 14 969 | 0,06% | Akcje |
| Police & Firemen's Retirement System of New Jersey | $146 420 | 14 775 | 0,05% | Akcje |
| Entropy Technologies, LP | $138 423 | 13 968 | 0,05% | Akcje |
| Green Alpha Advisors, LLC | $134 241 | 13 546 | 0,05% | Akcje |
| VANGUARD GROUP INC | $130 733 | 15 732 | 0,05% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $127 690 | 12 885 | 0,05% | Akcje |
Insiderzy spółki 17 insiderów · 5 dyrektorzy generalni · 13 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jason R Kelly | Chief Executive Officer & Founder | 28 lipca 2026 A | 3 894 680 | 0 | 0 | $0 |
| Steven P. Coen | Chief Financial Officer | 16 lipca 2026 M | 51 438 | 0 | 1 | $-5 941 |
| Mark E. Dmytruk | Chief Financial Officer | 20 maja 2025 M | 46 226 | 0 | 0 | $0 |
| Reshma P. Shetty | President & Founder | 28 lipca 2026 A | 12 374 544 | 0 | 0 | $0 |
| Marie E. Fallon | Chief Accounting Officer | 1 maja 2023 M | 183 010 | 0 | 0 | $0 |
| Sri Kosuri | Dyrektor | 11 czerwca 2026 A | 24 067 | 0 | 0 | $0 |
| Ross Fubini | Dyrektor | 11 czerwca 2026 A | 10 822 | 0 | 0 | $0 |
| Christian O Henry | Dyrektor | 11 czerwca 2026 A | 24 310 | 0 | 2 | $-219 800 |
| Harry Sloan | Dyrektor | 11 czerwca 2026 A | 271 418 | 0 | 0 | $0 |
| Shyam Sankar | Dyrektor | 12 czerwca 2025 A | 72 372 | 0 | 0 | $0 |
| Kathy Hopinkah Hannan | Dyrektor | 11 czerwca 2025 M | 15 003 | 0 | 0 | $0 |
| Myrtle S Potter | Dyrektor | 11 czerwca 2025 M | 10 822 | 0 | 0 | $0 |
| Arie Belldegrun | Dyrektor | 13 czerwca 2024 A | 194 925 | 0 | 0 | $0 |
| Reshma Kewalramani | Dyrektor | 12 czerwca 2024 M | 186 002 | 0 | 0 | $0 |
| Marijn E Dekkers | Dyrektor | 12 czerwca 2024 M | 386 480 | 0 | 0 | $0 |
| Eagle Equity Partners III, LLC | Dyrektor | 16 września 2021 D | 31 590 948 | 0 | 0 | $0 |
| Barry Canton | Posiadacz 10% | 28 lipca 2026 A | 12 374 544 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 4 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Reshma P. Shetty, Barry Canton | 14 lutego 2025 | 9,50% | Aneks | — | SEC |
| Jason Kelly ×4 zgłoszenia | 14 lutego 2024 | — | Pierwotne zgłoszenie | — | SEC |
| Reshma Shetty, Bartholomew Canton ×4 zgłoszenia | 14 lutego 2024 | — | Pierwotne zgłoszenie | — | SEC |
| VIKING GLOBAL INVESTORS LP, VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, O. ANDREAS HALVORSEN, DAVID C. OTT, ROSE S. SHABET ×3 zgłoszenia | 4 marca 2022 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 33 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| THNQ · EXCHANGE TRADED CONCEPTS TRUST | 0,84% | 321 721 NS | 30 kwietnia 2026 | N-PORT |
| IDNA · iShares Trust | 0,44% | 101 324 SH | 8 sierpnia 2026 | Dziennie |
| IWC · iShares Trust | 0,09% | 161 981 SH | 8 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 187 206 SH | 8 sierpnia 2026 | Dziennie |
| IBB · iShares Trust | 0,03% | 368 167 SH | 8 sierpnia 2026 | Dziennie |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,03% | 91 425 NS | 31 maja 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 41 498 SH | 8 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | 0,03% | 442 118 SH | 8 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,01% | 1 226 249 SH | 8 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,01% | 18 139 NS | 30 kwietnia 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 549 889 SH | 8 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 274 008 SH | 8 sierpnia 2026 | Dziennie |
| ITWO · ProShares Trust | 0,01% | 2 005 NS | 31 maja 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,01% | 112 735 SH | 8 sierpnia 2026 | Dziennie |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 210 534 NS | 31 maja 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 1 567 NS | 31 maja 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 16 982 NS | 30 kwietnia 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 1 584 NS | 31 maja 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 2 081 NS | 31 maja 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 4 528 NS | 30 kwietnia 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 40 NS | 31 maja 2026 | N-PORT |
| VEGN · ETF Series Solutions | 0,00% | 252 NS | 30 kwietnia 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 19 123 NS | 30 kwietnia 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 22 130 SH | 8 sierpnia 2026 | Dziennie |
| ITOT · iShares Trust | 0,00% | 66 432 SH | 8 sierpnia 2026 | Dziennie |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 26 477 NS | 31 maja 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 3 795 NS | 30 kwietnia 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 584 NS | 30 kwietnia 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 1 182 NS | 30 kwietnia 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 489 851 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 264 SH | 8 sierpnia 2026 | Dziennie |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 504 NS | 31 maja 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 1 232 NS | 30 kwietnia 2026 | N-PORT |